Filter
1593
Text search:
drug
registration
Featured
126
535
Language
Document type
1076
194
156
65
60
14
13
9
5
1
Countries / Regions
162
58
47
43
37
37
36
36
36
35
35
34
34
32
31
29
25
23
23
21
21
19
17
17
17
16
14
13
12
10
9
9
8
7
6
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
824
121
78
42
32
23
16
1
Toolboxes
176
149
75
72
71
40
36
29
25
25
23
17
16
15
13
7
7
6
5
5
2
2
2
Stop TB Communicable Diseases
On the road to ending TB
Highlights from the 30 highest TB burden countries
Experience of national TB partnerships
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Regional Analysis. WPSAR Vol 7, No 2, 2016 | doi: 10.5365/wpsar.2015.6.4.010
Innocenti Digest No. 13
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...
